血管活性肠肽、表皮生长因子上调支气管上皮细胞bcl-2基因表达

为探索肺内调节血管活性肠肽（ＶＩＰ）和表皮生长因子（ＥＧＦ）抗氧化保护的基因机制,用逆转录聚合酶链式反应（ＲＴ－ＰＣＲ）及Ｓｏｕｔｈｅｍｂｌｏｔ杂交等方法检测的代培养的兔支气管上皮（ＢＥＣ）内ｂｃｌ－２和ｃ－ｍｙｃ基因的表达中加入去甲肾上腺素观察ＶＩＰ、ＥＧＦ热应激对这两个基因表达的影响。结果显示：（１）基基础情况下ＢＥＣ内有ｂｃｌ－２和ｃ－ｍｙｃ基因的低水平表达;（２）ＥＧＦ和ＶＩＰ明显增强ｂｃ     

人γ干扰素（IFN－γ）－表皮生长因子（EGF）融合蛋白的抗肿瘤细胞增殖作用与靶细胞的EGF受体有关

采用表皮生长因子（ＥＧＦ）受体丰富的Ａ４３１细胞进一步研究了人ＩＦＮ－γ－ＥＧＦ３融合蛋白￣〔１〕的抗细胞分裂活性,以及它和靶细胞ＥＧＦ受体的关系。结果表明,ＩＦＮ－γ－ＥＧＦ３融合蛋白的抗肿瘤细胞增殖作用明显高于其母体分子。￣１２５Ｉ－ＥＧＦ受体竞争抑制试验表明,ＩＦＮ－γ可与ＥＧＦ竞争Ａ４３１细胞的ＥＧＦ受体,而ＩＮＦ－γ－ＥＧＦ３融合蛋白的ＥＧＦ受体竞争抑制作用更为明显,说明人ＩＦＮ－γ和ＩＦＮ－γ－ＥＧＦ３融合蛋白的抗肿瘤细胞分裂活性,与靶细胞ＥＧＦ受体被竟争抑制密切相关。     

表皮生长因子受体的分离与纯化

建立了一种从胎盘合胞体滋养层微绒毛膜蛋白中简单迅速两步纯化 EGFR 蛋 白的方法.用 Triton X-100 抽提微绒毛膜蛋白,使之两次通过 FPLC(Fast Pro-tein Liquid Chromatography)系统的 Superose 6 色谱柱纯化.SDS 胶电泳后,得到单一的 170000分子量 EGFR 蛋白带.纯化后的受体在 EGF,MnCl₂ 和 (γ-³²P)ATP 条件下,仍然保留胞内所具有的对 EGF 敏感的使受体自身磷酸化的蛋白激酶活性.     

表皮生长因子对细胞核转录活性的直接作用

表皮生长因子（ＥＧＦ）对纯化的鼠胚成纤维细胞（Ｃ３Ｈ１０Ｔ１／２Ｃ１８）胞核＾３Ｈ－ＵＴＰ掺入有明显的促进作用。这一作用在ＥＧＦ与细胞核共同培养９０ｍｉｎ时达到高峰。该作用是ＥＧＦ浓度依赖性的。ＥＧＦ对β射线转化的上述细胞的纯化细胞核,亦同样有促进转录作用。本实验所用的细胞核经光镜,电子显微镜观察,细胞膜、细胞浆标志酶检测及放射性同位素示踪法鉴定,未检出有核外成份的污染。本实验结果为膜受体信号传递     

肽类生长因子对抗癌基因的诱导作用

观察了肽类生长因子对２ＢＳ细胞中抗癌基因表达的影响,结果表明,ＥＧＦ或ＦＧＦ均可明显诱导２ＢＳ细胞中Ｒｂ基因的表达,其幅度分别为３０５％,２４３％;ＥＧＦ也可诱导２ＢＳ细胞中ＴＧＦβ１基因表达增加３０－５０％,但ＦＧＦ对ＴＧＦβ１的表达无明显影响;ＥＧＦ或ＦＧＦ对Ｐ５３基因的表达均无明显诱导作用。上述结果为生长因子作用机制研究及生长因子与抗癌基因的关系提供了新的线索。     

EGF类生长因子来源的新型靶向肽在抗肿瘤药物蛋白中的应用

许多肿瘤细胞表面表皮生长因子受体EGFR都存在过表达现象。考察了牛痘病毒生长因子(VGF)中的EGFR结合域(S3)与人的肝素样表皮生长因子(HB-EGF)来源的肝素结合域(命名为HE)重组后对肿瘤细胞的选择性。通过重组表达带有靶向和穿膜结构域的EGFP-S3-HE和EGFP-S3-HE-TATm两种融合蛋白与正常细胞和肿瘤细胞的共孵育实验来研究其对肿瘤细胞的特异性靶向吸附和穿膜效应。进一步将S3-HE-TATm靶向穿膜序列与苦瓜来源的核糖体失活蛋白MAP30融合,可显著提高MAP30对肿瘤细胞的抑杀作用,但这种抑杀作用却对正常细胞仍保持在较低水平。由此表明S3-HE-TATm是一种新型优异的肿瘤细胞靶向药物运输载体,可用于肿瘤治疗的进一步开发研究。     

人表皮生长因子肽谱及一级结构的质谱法分析

采用液相色谱－质谱联用法（ＬＣ－ＭＳ）,分别对基因工程表达的人表皮生长因子胰蛋白酶和Ｖ８蛋白酶的酶解产物进行了肽质谱分析,获得各肽段的分子量信息。并对大部分肽段用串联质谱（ＭＳ－ＭＳ）分析了肽的序列,获得其氨基酸序列信息。此外,还测定了分子中二硫键的数目。均获得满意的结果。这一方法的建立将有助于天然的,人工合成的及基因工程表达的蛋白质或多肽的鉴定和结构分析,其精确度及分辨率都超过常规方法。     

小鼠颌下腺表皮生长因子的分离、纯化与鉴定

雄性成年小鼠颌下腺醋酸提取物经Bio-Gel p-10凝胶层析可得七个色谱峰,经放射受体结合及放射免疫分析后,证实第七峰的EGF比活性最高。收集该组分,再经Sephadex G-10层析及DEAE-52离子交换层析,可得纯化的EGF样品。SDS-PAGE证明样品的分子量为6 000。RRA,RIA结果表明,样品与标准mEGF具有相同的受体结合活性及抗原性。生物学研究证明样品可以促进新生鼠睁眼和萌牙,刺激成纤维细胞DNA的生物合成。     

哺乳类(兔)红细胞分化因子的纯化及特性分析

本文报道从哺乳动物(兔)红细胞分离、提纯红细胞分化因子(ErythroidDifferentiation Factor,简称EDF及对其性质的分析。按Bishop方法给新西兰兔注射盐酸苯肼(2.5％)0.3mL/kg体重/日连续6days致贫血,收集血液用生理盐水洗去白细胞后,得到的网织红细胞用冻融法使细胞裂解,用乙醇、氯仿选择性变性除去血红蛋白,凝胶过滤,连续经DEAE-纤维素及CM-纤维素柱层析,取得较原裂解液纯化了31 000倍的活性物质EDF,产率为9.1％,分子量15kD,在SDS-PAGE电泳图中为单一蛋白带。EDF对热相对稳定,100℃处理10min仍保持一定活性,对蛋白酶敏咸而对DNA酶I及RNA酶不敏感。EDF对体外培养细胞的生长抑制作用已在体外实验体系得到验证。     

Localization of epidermal growth factor (EGF) and its receptor (EGFR) during postnatal testis development in the alpaca (Lama pacos)

The objective of the present studies was to determine the localization of epidermal growth factor (EGF) and the epidermal growth factor receptor (EGFR) in testicular tissue collected from male alpacas at 12 and 24 months of age. In the testes of 12-month-old alpacas, positive staining for EGF was not detected. EGFR was localized to Leydig cells within the 12-month-old alpaca testis, but staining was absent within seminiferous tubules. At 24 months of age, EGF was localized to Leydig cells, peritubular myoid cells, Sertoli cells and germ cells of the alpaca testis, with a preferential adluminal compartment staining within the seminiferous tubules. EGFR was also localized to the Leydig cells, peritubular myoid cells, Sertoli cells and germ cells within the 24-month-old alpaca testis, but staining within the tubules was primarily within the basal compartment. Results indicate distinct temporal and spatial regulation of EGF and EGFR in the alpaca testis and support a potential role for EGF and its related ligands in alpaca testis development and spermatogenesis.     

Purification and Characterization of Myosin from Calf Brain

Actomyosin complex was extracted from the brain cortex in a medium consisting of low salt, ATP, and EDTA, in the presence of protease inhibitors, followed by ammonium sulfate fractionation. Myosin was then purified from the actomyosin. Myosin obtained according to the procedure used was significantly contaminated with actin high (greater than 200,000 dalton) and low molecular weight proteins. Therefore, an alternative method based on affinity chromatography (Blue Dextran/Sepharose) and gel filtration (Sepharose 4B) was developed to purify myosin. This procedure yielded myosin that was greater than 95% pure as judged by electron microscopy and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The subunit composition of purified brain myosin was monitored by sodium dodecyl sulfate-polyacrylamide gel also containing a urea gradient. A closely migrating triplet in the heavy chain and three light chains, LC1, LC2, and LC3, of Mr 21,000, 19,000, and 17,000, respectively, were observed. These findings raise the possibility of the existence of myosin isoenzymes in the brain. Brain myosin formed bipolar thick filaments in 0.075 M KCl and MgCl2. At low ionic strength, the Mg2+-ATPase activity of myosin was stimulated 3- to 3.5-fold in the presence of skeletal muscle f-actin. Brain myosin also hydrolyzed other nucleotides; the rate of hydrolysis was ITP greater than ATP approximately equal to CTP greater than GTP approximately equal to UTP. The substrate (ATP) saturation curve in the presence of 10 mM CaCl2 and 0.6 M KCl was complex and consisted of plateau regions. The Arrhenius plot of the Ca-ATPase data was linear, whereas with ITPase, it was biphasic with a break occurring around 20 degrees C.     

Isolation and Identification of a New Thymic Peptide from Calf Thymus

Various thymic peptides (including thymulin, thymic humoral factor, thymopoietin, etc.) play important roles in the process of T cell maturation and development. We isolated a new peptide from calf thymus and named it thymus activity factor II (TAF-II). A yield of 0.92 mg of TAF-II was purified from 500 g calf thymus. Analysis by LC/MSD-Trap showed the amino acid sequence of this hexapeptide to be Glu-Ala-Lys-Ser-Gln-Gly-OH with molecular weight 618.5 daltons. We have also begun to investigate the influence of TAF-II.     

肽类生长因子对抗癌基因的诱导作用

观察了肽类生长因子对２ＢＳ细胞中抗癌基因表达的影响。结果表明,ＥＧＦ或ＦＧＦ均可明显诱导２ＢＳ细胞中Ｒｂ基因的表达,其幅度分别为３０５％、２４３％;ＥＧＦ也可诱导２ＢＳ细胞中ＴＧＦβ１基因表达增加３０－５０％,但ＦＧＦ对ＴＧＦβ１的表达无明显影响;ＥＧＦ或ＦＧＦ对ｐ５３基因的表达均无明显诱导作用。上述结果为生长因子作用机制研究及生长因子与抗癌基因的关系提供了新的线索。     

湖南烙铁头蛇毒中一个新的舒缓激肽增强肽（TmF）

通过 70 %冷甲醇抽提、SephadexG 15分子筛和反相高效液相色谱C1 8层析 ,从湖南产烙铁头蛇毒 (Trimeresurusmucrosquamatus)冻干粉中纯化得到一个新的舒缓激肽增强肽 (BPP) ,命名为TmF。该小肽的氨基酸序列为pGlu Gly Arg Pro Leu Gly Pro Pro Ile Pro Pro (pGlu表示焦谷氨酸 )。序列结果分析表明 ,TmF和已经分离得到的BPPs有很高的序列同源性。MSI MS测定其分子量为 1.110 7kD。TmF的生物学活性和药理学活性检测的结果表明 ,它增强舒缓激肽 (BK) ( 1mg L)诱导的离体豚鼠回肠纵行肌收缩的活性为 ( 1.13± 0 .3)单位 (mg L) ;TmF ( 5 .0× 10 - 4mg kg)可以增强约 ( 14± 2 )mmHg的由BK( 5 .0× 10 - 5mg kg)诱导的舒张压下降 ;在抑制剂试验中 ,不同剂量的TmF和 5× 10 - 2 mg的血管紧张素转化酶保温 30min ,结果表明大约2 .0× 10 - 3mg的TmF表现出对ACE水解活性的半数抑制率 (IC50 )。     

家蝇天然抗菌肽的分离纯化与活性分析

目的:纯化得到有抗菌活性的家蝇天然抗菌肽。方法:以革兰氏阴性菌(大肠杆菌)和革兰氏阳性菌(金黄色葡萄球菌)的混合菌液,在未灭活的情况下对家蝇幼虫实施带菌针刺以诱导抗菌肽的大量表达。采用固相萃取(SPE),得到三个对大肠杆菌和金黄色葡萄球菌均有强烈抑制作用的组分Sp1、Sp3和Sp8。用反相高效液相色谱(RP-HPLC)对活性最强的Sp1进行了纯化,液体生长抑制法证明其中的组分Ⅲ具有最强活性。毛细管电泳(CE)显示该组分由两种物质组成。结果和结论:家蝇血淋巴中存在大量有抗菌活性的物质。该研究利用SPE和RP-HPLC与CE联用的方法,得到了有较强抗菌活性和较宽抗菌谱的粗提物,并获得一个推测由两种阳离子型抗菌肽组成的成分,为后期研究打下了基础。     

从抗TNF抗体的CDR肽库中获得拮抗TNF的短肽

为设计来自抗体的短肽 ,以抗肿瘤坏死因子 (TNF)嵌合抗体 (cA2 )CDRs为模板 ,在其两侧各加 3个随机氨基酸残基 ( X3 CDR X3 ) ,构建了 6个以CDR为基础的肽库 .经过 3轮亲和选择 ,挑取单克隆 ,进一步经ELISA检测TNF阳性噬菌体克隆 ,分离得到 7个ELISA阳性较好的噬菌体肽克隆 ,分别命名为CDR2L1、CDR2L2、CDR2L3、CDR1L1、CDR2H1、CDR3H1、CDR3H 2 .应用MTT方法 ,检测 7个克隆对TNF生物学活性的拮抗作用 .结果显示 :来自CDR2L ,CDR3H肽库中的CDR2L2、CDR2L3,CDR3H2噬菌体肽具有明显的拮抗TNF诱导L92 9细胞的细胞毒作用 ,其中以CDR2L2噬菌体肽的拮抗活性最强 .而来源于CDR1L ,CDR2H肽库的CDR1L1和CDR2H1噬菌体肽和来自CDR2L ,CDR3H肽库中的CDR2L1和CDR3H1噬菌体肽没有明显的拮抗TNF作用 .研究结果初步表明 :从cA2抗体CDR肽库中筛选得到的噬菌体CDR模拟肽具有亲本抗体相似的结合活性和生物学效应 ,从而为开发已知抗体 (特别是治疗用抗体 )CDR为基础的肽药物创建一个技术平台奠定基础     

Peptide binding to intestinal epithelium: distinct sites for insulin, EGF and VIP

Several peptides, including insulin, epidermal growth factor and vasoactive intestinal polypeptide bind to intestinal epithelial cells. However, it is unclear whether one binding site binds several peptides or whether separate sites exist for each peptide. These studies were designed to examine the specificity of peptide binding sites on intestinal epithelial cells. Peptide binding was measured directly with [125I]radiolabelled peptides to isolated enterocytes prepared from rabbit ileum. The characteristics of insulin and epidermal growth factor binding were similar. Both insulin and epidermal growth factor specific binding was saturable, directly correlated to cell concentration and temperature and pH dependent. The total number of insulin binding sites per cell was 4500, that for epidermal growth factor was 2280. Scatchard analysis for both peptides produced curvilinear plots. Dissociation of both peptides from the binding site was increased in the presence of their respective unlabelled peptide. However, insulin specific binding was not altered by epidermal growth factor, and epidermal growth factor specific binding was unaffected by insulin. Further, both insulin and epidermal growth factor failed to inhibit the specific binding of vasoactive intestinal polypeptide to ileal enterocytes, and vasoactive intestinal polypeptide did not inhibit insulin or epidermal growth factor specific binding. These studies demonstrate that insulin, epidermal growth factor and vasoactive intestinal polypeptide interact with three distinct membrane binding sites on the enterocyte.